Cargando…
Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report
BACKGROUND: Antipsychotic drug treatment can potentially lead to adverse events such as leukopenia and neutropenia. Although these events are rare, they represent serious and life-threatening hematological side effects. CASE PRESENTATION: We present a case study of a patient with schizoaffective dis...
Autores principales: | Matsuura, Hiroki, Kimoto, Sohei, Harada, Izumi, Naemura, Satoshi, Yamamuro, Kazuhiko, Kishimoto, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880967/ https://www.ncbi.nlm.nih.gov/pubmed/27229149 http://dx.doi.org/10.1186/s12888-016-0874-x |
Ejemplares similares
-
Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorder
por: Yamamuro, Kazuhiko, et al.
Publicado: (2014) -
Role of paliperidone extended-release in treatment of schizoaffective disorder
por: Canuso, Carla M, et al.
Publicado: (2010) -
Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada, Ryohei, et al.
Publicado: (2018) -
Potential primary roles of glial cells in the mechanisms of psychiatric disorders
por: Yamamuro, Kazuhiko, et al.
Publicado: (2015) -
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
por: Greenberg, William M., et al.
Publicado: (2015)